High risk of neutropenia for hormone-naive prostate cancer patients receiving STAMPEDE-style upfront Docetaxel chemotherapy in usual clinical practice

Tanguay, J. S., Catlow, Charles Richard A. ORCID: https://orcid.org/0000-0002-1341-1541, Smith, C., Barber, J., Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Kumar, S., Palaniappan, N., Button, M. and Mason, Malcolm David ORCID: https://orcid.org/0000-0003-1505-2869 2016. High risk of neutropenia for hormone-naive prostate cancer patients receiving STAMPEDE-style upfront Docetaxel chemotherapy in usual clinical practice. Clinical Oncology 28 (9) , p. 611. 10.1016/j.clon.2016.03.006

Preview

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (17kB) | Preview

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Chemistry Medicine
Publisher:	Elsevier
ISSN:	0936-6555
Date of First Compliant Deposit:	14 September 2017
Last Modified:	29 Nov 2024 09:00
URI:	https://orca.cardiff.ac.uk/id/eprint/102660

Citation Data

Cited 8 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item